Cigna Group (NYSE:CI) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Cigna Group (NYSE:CI) from a hold rating to a buy rating in a report published on Sunday morning,Wall Street Zen reports.

Several other equities research analysts have also commented on CI. Evercore began coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price objective on the stock. Guggenheim dropped their target price on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating for the company in a report on Friday, November 6th. Barclays lifted their target price on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Robert W. Baird set a $362.00 price target on shares of Cigna Group in a report on Friday, July 31st. Finally, Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $336.20.

Cigna Group Stock Performance

NYSE CI opened at $302.30 on Friday. The business has a 50 day moving average price of $286.66 and a 200 day moving average price of $282.38. The company has a market capitalization of $79.66 billion, a P/E ratio of 9.35, a PEG ratio of 1.10 and a beta of 0.25. Cigna Group has a 1-year low of $257.85 and a 1-year high of $318.05. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46. The company had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. Cigna Group’s quarterly revenue was up 5.6% compared to the same quarter last year. During the same period in the previous year, the business earned $7.83 earnings per share. Sell-side analysts expect that Cigna Group will post 30.70 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is presently 27.54%.

Insiders Place Their Bets

In related news, insider Everett Neville sold 617 shares of the business’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cigna Group

Institutional investors have recently modified their holdings of the company. Evercore Wealth Management LLC boosted its position in Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after acquiring an additional 35 shares during the last quarter. Independence Bank of Kentucky raised its holdings in Cigna Group by 2.6% in the 2nd quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock valued at $409,000 after acquiring an additional 37 shares during the last quarter. West Family Investments Inc. raised its holdings in Cigna Group by 4.2% in the 2nd quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock valued at $253,000 after acquiring an additional 37 shares during the last quarter. Maripau Wealth Management LLC lifted its stake in shares of Cigna Group by 4.0% during the 1st quarter. Maripau Wealth Management LLC now owns 1,074 shares of the health services provider’s stock worth $287,000 after purchasing an additional 41 shares during the period. Finally, Capital City Trust Co. FL lifted its stake in shares of Cigna Group by 0.6% during the 2nd quarter. Capital City Trust Co. FL now owns 6,380 shares of the health services provider’s stock worth $1,759,000 after purchasing an additional 41 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Recent coverage says strong Q3 growth has lifted Cigna’s 2026 earnings outlook, offering a favorable signal about business performance and the company’s earnings trajectory. The Cigna Group stock: Higher outlook follows strong Q3 performance
• Positive Sentiment: Barclays raised its price target to $320 from $310, implying potential upside from the referenced $302.30 price. However, it maintained an “equal weight” rating, indicating a balanced rather than strongly bullish view. Barclays price target update
• Neutral Sentiment: The Cigna Group Foundation awarded $3.45 million to 23 nonprofits supporting housing stability and mental health for veterans and their families. This highlights community investment but is not likely to have a significant direct effect on earnings. Cigna Foundation veteran grants
• Neutral Sentiment: Cigna’s CFO is scheduled to speak at the UBS Global Healthcare Conference, which could provide investors with updates but is not itself a financial announcement. UBS Global Healthcare Conference appearance
• Neutral Sentiment: Cigna Healthcare Hong Kong is expanding access to Headspace’s self-guided mental-wellbeing resources. The partnership may support its service offering, though the report provides no financial impact. Headspace resources in Hong Kong
• Negative Sentiment: Guggenheim cut its price target for Cigna, a cautious counterpoint to Barclays’ increase. The report provided here does not specify the revised target or rating. Guggenheim price target update

Cigna Group Company Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.